Of the 268 patients with oesophageal cancer (171 men) available for analysis, 131 (49%) cancers were ofsquamous cell type, 95 (36%) were adenocarcinomas, 19 (7%) were anaplastic, and the remaining 23 (6%) were of unknown histology.
Abstract
The place of radiotherapy in the management of squamous cell oesophageal cancer remains uncertain. Survival of oesophageal cancer patients from the Nottingham area in the years 1982-5 was reviewed. Surgical resection was attempted in 44 of 131 patients with squamous cell oesophageal cancer. Among the remainder 32 had endoscopic intubation alone, 27 had radical radiotherapy alone (six) or combined with endoscopic intubation (21), and 28 had other treatment combinations including surgical intubation and palliative radiotherapy. Patients treated by intubation alone had a mean age of 75 years. They were significantly older and metastases were more common (31%) in this group than in patients treated with radiotherapy (mean age 69 years), of whom 11% had metastases. Some 34% (11 of Survival in the radiotherapy group (Fig 1) was Time from diagnosis (mths) significantly greater than in the group who had intubation alone (logrank X2=7-9, p<0005).
Median (confidence intervals (CI)) survival in the radiotherapy group was 188 (133-253) days, and the survival rate was 52% at six months and 11% at one year. In the intubation group there was a median (CI) survival of 75 (31-98) days and survival rates of 13% and 7% at six months and one year respectively (Table II) . The surgical group had a median (CI) survival of 364 (255-465) days and survival rates of 98%, 80%, and 48% at 30 days, six months, and one year respectively.
Intubation was often carried out to relieve dysphagia before deciding whether to offer radiotherapy. To receive radiotherapy therefore patients had to survive the early stages of their hospital admission, and, in most cases, recover from an intubation procedure. To make some allowance for this selection effect, survival of the two groups has been compared after excluding all deaths within 30 days of diagnoses (Fig 2) 
